Atlas Trials

Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray

Clinical trial NCT03755557 · COMPLETED

Trial details

NCT number
NCT03755557
Sponsor
Marinomed Biotech AG
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergic RhinitisAllergic ConjunctivitisHayfever
Start date
2018-11-19
Primary completion
2019-04-05
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.